Antiproliferative activity and apoptosis induced by6-bromo-2-(morpholin-1- yl)-4-amlinoquinazoline on cells of leukemia lines

Experimental Oncology

Volumn 30, Issue 2, 2008, Pages 139-142

  Jantova, S ^a   Repicky, A ^a   Paulovicova, E ^b   Letasiova, S ^a   Cipak, L ^c  

^a SLOVAK UNIVERSITY OF TECHNOLOGY   (Slovakia)

^b INSTITUTE OF CHEMISTRY   (Slovakia)

^c CANCER RESEARCH INSTITUTE   (Slovakia)

Author keywords

Apoptosis; Leukemia; Quinazoline

Indexed keywords

6 BROMO 2 (MORPHOLIN 1 YL) 4 ANILINOQUINAZOLINE; BROMINE DERIVATIVE; CASPASE 3; CISPLATIN; DNA FRAGMENT; MORPHOLINE DERIVATIVE; QUINAZOLINE DERIVATIVE; TRYPAN BLUE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL COUNT; CELL CYCLE; CELL PROLIFERATION; CELL STRAIN HL 60; CELL STRAIN U937; COLORIMETRY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; LEUKEMIA; LEUKEMIA L 1210; STAINING;

ANILINE COMPOUNDS; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; DNA FRAGMENTATION; DRUG SCREENING ASSAYS, ANTITUMOR; HL-60 CELLS; HUMANS; INHIBITORY CONCENTRATION 50; MICE; MICROSCOPY, FLUORESCENCE; MODELS, CHEMICAL; QUINAZOLINES; U937 CELLS;

EID: 46749097971     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Abdel-Rahman TM. Synthesis of some new biologically active 2,3-disubstituted quinazolin-4-ones. Boll Chim Farm 1998; 137: 43-7.
2. Kornet MJ. Synthesis and anticonvulsant activity of 3-alkyl-3,4-dihydro-2(1H)-quinazolinones. J Heterocyclic Chem 1992; 29: 103-5.
3. Jantova S, Letasiova S, Repicky A, et al. The effect of 3-(5-nitro-2-thienyl)-9-chloro-5-morpholin-4-yl-[l,2,4] triazolo[4,3-c] quinazoline on cell growth, cell cycle, induction of DNA fragmentation, and activity of caspase in murine leukemia L1210 cells and fibroblast NIH-3T3 cells. Cell Biochem Funct 2006; 24: 519-30.
4. Cipak L, Repicky A, Jantova S. Growth inhibition and apoptosis induced by 2-phenoxymethyl-3H-quinazolin-4-one in HL-60 leukemia cells. Exp Oncol 2007; 29: 13-7.
5. Tonkinson JL, Marder P, Andis SL, et al. Cell cycle effects of antifolate antimetabolites: implications for cytotoxicity and cytostatis. Cancer Chemother Pharmacol 1997; 39: 521-31.
6. Takemura Y, Jackman A. Folate-based thymidylate synthase inhibitors in cancer chemotherapy. Anti-Cancer Drugs 1997; 8: 3-16.
7. Al-Rashood ST, Aboldahab IA, Nagi MN, et al. Synthesis, dihydrofolate reductase inhibition, antitumor testing, and molecular modeling study of some new 4(3H)-quinazolinone analogs. Bioorg Med Chem 2006; 14: 8608-21.
8. Hamel E, Lin CM, Plowman J, et al. Antitumour 2,3-di-hydro-2-(aryl)-4(1H)-quinazolinone derivatives. Interactions with tubulin. Biochem Pharmacol 1996; 51: 53-9.
9. Huang S, Armstrong EA, Benavente S, et al. Dual-agent molecular targeting of the epidermal growth factor receptor (EGFR): combining anti-EGFR antibody with tyrosine kinase inhibitor. Cancer Res 2004; 64: 5355-62.
10. Holden SA, Teicher BA, Robinson MF, et al. Antifolates can potentiate topoisomerase II inhibitors in vitro and in vivo. Cancer Chemother 1995; 36: 165-71.
11. Stankovsky S, Martvon A. Synthesis of substituted 4-anilinoquinazolines. Coll Czech Chem Comm 1979; 45: 1079-85.
12. Stankovsky S, Mrazova D. Preparation of substituted 2-phenyl-4-anilinoquinazolines through imidoylcarbodiimides. Chem Papers 1983; 38: 549-55.
13. Gottasova R, Kubikova J, Cipak L. Antibacterial effect of some 2,6-disubstituted 4-anilinoquinazolines. Folia Microbiol 1998; 43: 679-82.
14. Jantova S, Urbancikova M, Maliar T, et al. Biological activity of some 4-anilinoquinazolines: cytotoxic, genotoxic and antiprotease effects, induction of necrosis and changes of actin cytoskeleton. Neoplasma 2001; 48: 52-60.
15. Lowry OH, Rosebrough NJ, Farr AL, Randal RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 143: 265.
16. Pfeiler G, Horn F, Lattrich C, et al. Apoptotic effects of signal transduction inhibitors on human tumor cells with different PTEN expression. Oncol Rep 2007; 18: 1305-9.
17. Philchenkov A. Caspases: potential targets for regulating cell death. J Cell Mol Med 2004; 8: 432-44.